In June 2026, Qingdao Sunrise Health participated in two major industry benchmark exhibitions in Shanghai, achieving comprehensive brand showcases and business collaborations across the entire industrial chain, yielding fruitful cooperation outcomes. The 16th HNC China International Health Products Exhibition was held at the Shanghai Hongqiao National Exhibition and Convention Center from June 15 to 17, with the company exhibiting at booth H3-3G50; shortly thereafter, the 24th CPHI China International Pharmaceutical Raw Materials Exhibition took place at booth E4C02 of the Shanghai New International Expo Center from June 16 to 18. Both exhibitions simultaneously focused on covering the two core sectors of health consumption and pharmaceutical raw materials.

As a leading benchmark in the Asia-Pacific health and nutrition consumer sector, HNC targets brand owners, channel distributors, and domestic chain wellness institutions. Sunrise Health focused on showcasing organic powders, functional gummies, dietary soft capsules, and compound formulations combining medicinal and edible ingredients, while also promoting one-stop OEM/ODM customization services. Leveraging its technical expertise in contributing to the development of the group standard for "Functional Nutritional Gummies," the company demonstrated standardized production processes and comprehensive quality control capabilities to domestic clients, attracting a steady stream of potential customers for on-site discussions.

CPHI is the global core platform for pharmaceutical raw material supply chains, bringing together pharmaceutical companies worldwide and international import/export buyers. The exhibition booth focuses on natural plant extracts, pharmaceutical-grade functional ingredients, and high-purity active pharmaceutical ingredients (APIs), comprehensively showcasing the entire industrial chain technology from raw material extraction to formulation development. It highlights key strengths including international organic certification, large-scale GMP production, and compliant exports to over 100 countries, effectively addressing overseas pharmaceutical procurement and contract manufacturing needs.

During the exhibition period, the team received over 1,000 visits from professional buyers both domestically and internationally, establishing cooperation agreements with multiple domestic health brands and overseas pharmaceutical traders regarding sample exchanges, long-term supply arrangements, and joint R&D initiatives. Concurrently, discussions were held on the latest industry policies, raw material innovations, and trends in standardization development.

This dual-track participation represents a pivotal strategic move by Sunrise Health to bridge the raw material supply chain with the end-user health market. Moving forward, the company will continue to focus on the bio-functional nutrition sector, leveraging high-standard R&D, consistent quality assurance, and global services to collaborate with domestic and international partners, thereby fostering the standardized and internationalized development of China's functional food and pharmaceutical raw material industries.